BND yields 3.91% · MRK yields 3.25%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, BND + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BND + MRK for your $10,000?
The fund’s investment objective is to seek to track the performance of a broad, market-weighted bond index. The fund generally: Provides broad exposure to the taxable investment-grade U.S. dollar-denominated bond market, excluding inflation-protected and tax-exempt bonds. Offers relatively high potential for investment income; share value tends to rise and fall modestly. May be more appropriate for medium- or long-term goals where you’re looking for a reliable income stream. Is appropriate for diversifying the risks of stocks in a portfolio.
Full BND Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.